{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:06:28Z","timestamp":1792613188284,"version":"4.5.0"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CSAINV21nov-0003"],"award-info":[{"award-number":["CSAINV21nov-0003"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CSASI24jul-0005"],"award-info":[{"award-number":["CSASI24jul-0005"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.smim.2025.101959","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T08:54:09Z","timestamp":1745312049000},"page":"101959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Immune dysregulation of diabetes in tuberculosis"],"prefix":"10.1016","volume":"78","author":[{"given":"Pei Min","family":"Thong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Hao","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardy","family":"Kornfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine W.M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2025.101959_bib1","unstructured":"International Diabetes Federation, IDF Diabetes Atlas, 10th edition. Brussels, Belgium: International Diabetes Federation, 2021."},{"key":"10.1016\/j.smim.2025.101959_bib2","unstructured":"World Health Organisation, Global Tuberculosis Report 2023, 2023, World Health Organisation: Geneva, Switzerland."},{"issue":"10","key":"10.1016\/j.smim.2025.101959_bib3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/tmi.13133","article-title":"Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis","volume":"23","author":"Hayashi","year":"2018","journal-title":"Trop. Med. Int. Health"},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5588\/ijtld.22.0685","article-title":"Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes","volume":"27","author":"Goletti","year":"2023","journal-title":"Int. J. Tube Lung Dis."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13098-021-00743-3","article-title":"Global, regional, and national prevalence of diabetes mellitus in patients with pulmonary tuberculosis: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12879-023-08502-7","article-title":"Facilitators and barriers to tuberculosis active case findings in low- and middle-income countries: a systematic review of qualitative research","volume":"23","author":"Fenta","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.smim.2025.101959_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijid.2017.01.018","article-title":"The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications","volume":"56","author":"Girardi","year":"2017","journal-title":"Int J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3201\/eid2503.180572","article-title":"Epidemiology of extrapulmonary tuberculosis among inpatients, China, 2008-2017","volume":"25","author":"Pang","year":"2019","journal-title":"Emerg. Infect. Dis."},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib10","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/infdis\/jiw436","article-title":"Impaired recognition of mycobacterium tuberculosis by alveolar macrophages from diabetic mice","volume":"214","author":"Martinez","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib11","article-title":"Diabetes and tuberculosis","volume":"4","author":"Restrepo Blanca","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.smim.2025.101959_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46477","article-title":"Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity","volume":"8","author":"Kumar","year":"2019","journal-title":"eLife"},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/crj.13405","article-title":"Clinical features in pulmonary tuberculosis patients combined with diabetes mellitus in China: an observational study","volume":"15","author":"Tong","year":"2021","journal-title":"Clin. Respir. J."},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4269\/ajtmh.2008.79.541","article-title":"Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes","volume":"79","author":"Restrepo","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw126","article-title":"Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis","volume":"3","author":"Salindri","year":"2016","journal-title":"Open Forum Infect. Dis."},{"issue":"12","key":"10.1016\/j.smim.2025.101959_bib16","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/jac\/dkz368","article-title":"Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients","volume":"74","author":"Mtabho","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib17","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.4049\/jimmunol.1000304","article-title":"Diabetic mice display a delayed adaptive immune response to mycobacterium tuberculosis","volume":"184","author":"Vallerskog","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13643-018-0828-0","article-title":"Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis","volume":"7","author":"Tegegne","year":"2018","journal-title":"Syst. Rev."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092623","article-title":"Diabetes and risk of tuberculosis relapse: nationwide nested case-control study","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tmi.12120","article-title":"Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania","volume":"18","author":"Faurholt-Jepsen","year":"2013","journal-title":"Trop. Med. Int. Health"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib21","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/s41598-021-81057-2","article-title":"Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis","volume":"11","author":"Gautam","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/cid\/cix819","article-title":"Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment","volume":"66","author":"Degner","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.smim.2025.101959_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.691823","article-title":"Pre-diabetes increases tuberculosis disease severity, while high body fat without impaired glucose tolerance is protective","volume":"11","author":"Sinha","year":"2021","journal-title":"Front Cell Infect. Microbiol"},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153590","article-title":"Glucose metabolism disorder is associated with pulmonary tuberculosis in individuals with respiratory symptoms from Brazil","volume":"11","author":"Almeida-Junior","year":"2016","journal-title":"PLOS ONE"},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/tmi.14034","article-title":"Prediabetes and the treatment outcome of tuberculosis: a meta-analysis","volume":"29","author":"Liang","year":"2024","journal-title":"Trop. Med. Int. Health"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib26","article-title":"Post tuberculosis radiological sequelae in patients treated for pulmonary and pleural tuberculosis at a tertiary center in Pakistan","volume":"92","author":"Zubair","year":"2021","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217289","article-title":"Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD","volume":"14","author":"Gupte","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2025.101959_bib28","article-title":"Impact of intermediate hyperglycaemia as well as diabetes on immune dysfunction in tuberculosis","author":"Eckold","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1375","article-title":"Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity","volume":"13","author":"Eckold","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib30","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1038\/s41598-023-34847-9","article-title":"A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction","volume":"13","author":"Queiroz","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jinf.2016.08.021","article-title":"Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors","volume":"74","author":"Kumar","year":"2017","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12879-018-3246-y","article-title":"Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment","volume":"18","author":"Kumar","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1513\/AnnalsATS.201305-112OC","article-title":"Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines","volume":"10","author":"Kumar","year":"2013","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146318","article-title":"Circulating angiogenic factors as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis","volume":"11","author":"Kumar","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.tube.2015.06.004","article-title":"Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines","volume":"95","author":"Kumar","year":"2015","journal-title":"Tuberc. (Edinb., Scotl. )"},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/infdis\/jit241","article-title":"Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus","volume":"208","author":"Kumar","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/590565","article-title":"Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells","volume":"47","author":"Restrepo","year":"2008","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/imm.12421","article-title":"Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis","volume":"144","author":"Kumar","year":"2015","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib39","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ajpath.2013.12.015","article-title":"Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity","volume":"184","author":"Podell","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1165\/rcmb.2006-0478OC","article-title":"Tuberculosis susceptibility of diabetic mice","volume":"37","author":"Martens","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.smim.2025.101959_bib41","doi-asserted-by":"crossref","first-page":"1244556","DOI":"10.3389\/fimmu.2023.1244556","article-title":"Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences","volume":"14","author":"Aiello","year":"2023","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1054\/tuld.1998.0167","article-title":"Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis","volume":"79","author":"Wang","year":"1999","journal-title":"Tuber. Lung Dis."},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000474","article-title":"MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis","volume":"5","author":"Bowdish","year":"2009","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib44","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.micinf.2016.03.007","article-title":"Signalling through MyD88 drives surface expression of the mycobacterial receptors MCL (Clecsf8, Clec4d) and Mincle (Clec4e) following microbial stimulation","volume":"18","author":"Kerscher","year":"2016","journal-title":"Microbes Infect."},{"key":"10.1016\/j.smim.2025.101959_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2013.00005","article-title":"Recognition of the mycobacterial cord factor by Mincle: relevance for granuloma formation and resistance to tuberculosis","volume":"4","author":"Lang","year":"2013","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.smim.2025.101959_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.micinf.2020.03.004","article-title":"Increased susceptibility to Mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes","volume":"22","author":"Alim","year":"2020","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/iai.65.1.298-304.1997","article-title":"Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis","volume":"65","author":"Keane","year":"1997","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib49","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.4049\/jimmunol.160.11.5448","article-title":"Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular mycobacterium tuberculosis1","volume":"160","author":"Oddo","year":"1998","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2025.101959_bib50","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm906","article-title":"Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis","volume":"9","author":"Schaible","year":"2003","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.smim.2025.101959_bib51","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1128\/IAI.68.12.6954-6961.2000","article-title":"Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent","volume":"68","author":"Bekker","year":"2000","journal-title":"Infect. Immun."},{"issue":"6600","key":"10.1016\/j.smim.2025.101959_bib52","doi-asserted-by":"crossref","first-page":"eabh2841","DOI":"10.1126\/science.abh2841","article-title":"Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport","volume":"376","author":"Roca","year":"2022","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.smim.2025.101959_bib53","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.96.10.5657","article-title":"Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system","volume":"96","author":"Tsenova","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/ajrccm.159.1.9803066","article-title":"Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis","volume":"159","author":"Casarini","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib55","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/IAI.68.6.3322-3326.2000","article-title":"Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection","volume":"68","author":"Saunders","year":"2000","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tube.2012.10.003","article-title":"Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control","volume":"93","author":"Gomez","year":"2013","journal-title":"Tuberc. (Edinb. )"},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092977","article-title":"Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia","volume":"9","author":"Restrepo","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/imm.12496","article-title":"Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity","volume":"146","author":"Kumar","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2025.101959_bib59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tube.2016.10.004","article-title":"Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment","volume":"101","author":"Kumar","year":"2016","journal-title":"Tuberc. (Edinb. )"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib60","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-020-19412-6","article-title":"Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis","volume":"11","author":"Moreira-Teixeira","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib61","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1164\/rccm.201304-0803OC","article-title":"S100A8\/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis","volume":"188","author":"Gopal","year":"2013","journal-title":"Am. J. Respir. Crit. care Med."},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004917","article-title":"Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis","volume":"11","author":"Ong","year":"2015","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chom.2012.07.009","article-title":"Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages","volume":"12","author":"Yang","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib64","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1172\/JCI31097","article-title":"Neutrophil-mediated innate immune resistance to mycobacteria","volume":"117","author":"Martineau","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib65","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41598-017-01767-4","article-title":"Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications","volume":"7","author":"Prada-Medina","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib66","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1378\/chest.13-1799","article-title":"Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity","volume":"145","author":"Andrade","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2249.2006.03211.x","article-title":"Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy","volume":"146","author":"Brahmbhatt","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2025.101959_bib68","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.micinf.2015.03.013","article-title":"Bacillary replication and macrophage necrosis are determinants of neutrophil recruitment in tuberculosis","volume":"17","author":"Repasy","year":"2015","journal-title":"Microbes Infect."},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib69","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1462-5822.2012.01783.x","article-title":"Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils","volume":"14","author":"Corleis","year":"2012","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.smim.2025.101959_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102426","article-title":"Necrosis, netosis, and apoptosis in pulmonary tuberculosis and type-2 diabetes mellitus. Clues from the patient's serum","volume":"143","author":"Rojas-Espinosa","year":"2023","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003190","article-title":"Intracellular bacillary burden reflects a burst size for mycobacterium tuberculosis in vivo","volume":"9","author":"Repasy","year":"2013","journal-title":"PLoS Pathog."},{"issue":"5663","key":"10.1016\/j.smim.2025.101959_bib72","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil EXtracellular Traps Kill Bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023637","article-title":"Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR","volume":"6","author":"Young","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2008.09.009","article-title":"Neutrophil extracellular traps are induced by Mycobacterium tuberculosis","volume":"89","author":"Ramos-Kichik","year":"2009","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12950-023-00329-y","article-title":"Neutrophil extracellular traps and pulmonary fibrosis: an update","volume":"20","author":"Yan","year":"2023","journal-title":"J. Inflamm. (Lond. )"},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib76","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4049\/jimmunol.1900235","article-title":"Intracellular neutrophil oxidants: from laboratory curiosity to clinical reality","volume":"202","author":"Dahlgren","year":"2019","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib77","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jlb.67.3.396","article-title":"Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase","volume":"67","author":"Karlsson","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib78","first-page":"155","article-title":"Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus","volume":"5","author":"Osar","year":"2004","journal-title":"Exp. Diabesity Res."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.micinf.2014.11.009","article-title":"Increased resistin may suppress reactive oxygen species production and inflammasome activation in type 2 diabetic patients with pulmonary tuberculosis infection","volume":"17","author":"Chao","year":"2015","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib80","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/diacare.24.1.104","article-title":"Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients","volume":"24","author":"Shurtz-Swirski","year":"2001","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib81","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","article-title":"Molecular and cellular mechanisms of cardiovascular disorders in diabetes","volume":"118","author":"Shah","year":"2016","journal-title":"Circ. Res"},{"key":"10.1016\/j.smim.2025.101959_bib82","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3389\/fimmu.2020.01649","article-title":"Mitochondrial reactive oxygen species: double-edged weapon in host defense and pathological inflammation during infection","volume":"11","author":"Silwal","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib83","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib84","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2013.03.022","article-title":"TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species","volume":"153","author":"Roca","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib85","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib86","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4049\/jimmunol.172.1.130","article-title":"NK cells regulate CD8+\u2009T cell effector function in response to an intracellular pathogen 1","volume":"172","author":"Vankayalapati","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib87","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.168.7.3451","article-title":"The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium1","volume":"168","author":"Vankayalapati","year":"2002","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib88","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/jdi.13002","article-title":"Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes","volume":"10","author":"Kim","year":"2019","journal-title":"J. Diabetes Investig."},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062418","article-title":"Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes","volume":"8","author":"Berrou","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2025.101959_bib90","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/RMHP.S354377","article-title":"Impact of Diabetes Mellitus on the Immunity of Tuberculosis Patients: A Retrospective, Cross-Sectional Study","volume":"15","author":"Wei","year":"2022","journal-title":"Risk Manag Health Policy"},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib91","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4161\/viru.22586","article-title":"The role of dendritic cells in Mycobacterium tuberculosis infection","volume":"3","author":"Mihret","year":"2012","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib92","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.173.1.494","article-title":"Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis","volume":"173","author":"Marino","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib93","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1756-0500-4-247","article-title":"Dendritic cells activate and mature after infection with mycobacterium tuberculosis","volume":"4","author":"Mihret","year":"2011","journal-title":"BMC Res. Notes"},{"issue":"2000","key":"10.1016\/j.smim.2025.101959_bib94","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib95","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-2007-990278","article-title":"Reduced frequency of peripheral dendritic cells in type 2 diabetes","volume":"116","author":"Seifarth","year":"2008","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib96","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbadis.2016.01.001","article-title":"High glucose and hyperglycemic sera from type 2 diabetic patients impair DC differentiation by inducing ROS and activating Wnt\/\u03b2-catenin and p38 MAPK","volume":"1862","author":"Gilardini Montani","year":"2016","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib97","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.1401125","article-title":"Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia","volume":"193","author":"Martinez","year":"2014","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2025.101959_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008140","article-title":"IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis","volume":"15","author":"Tripathi","year":"2019","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib99","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/mi.2017.15","article-title":"Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection","volume":"10","author":"Treerat","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2025.101959_bib100","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.3389\/fimmu.2018.02209","article-title":"IL-22: an underestimated player in natural resistance to tuberculosis?","volume":"9","author":"Ronacher","year":"2018","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib101","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-016-1391-6","article-title":"Biological and pathological activities of interleukin-22","volume":"94","author":"Perusina Lanfranca","year":"2016","journal-title":"J. Mol. Med (Berl. )"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib102","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/imm.12632","article-title":"Effect of standard tuberculosis treatment on naive, memory and regulatory T-cell homeostasis in tuberculosis-diabetes co-morbidity","volume":"149","author":"Kumar","year":"2016","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib103","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133788","article-title":"BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus mice","volume":"5","author":"Radhakrishnan","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib104","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","article-title":"CD8 T cells and Mycobacterium tuberculosis infection","volume":"37","author":"Lin","year":"2015","journal-title":"Semin Immunopathol."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.165.1.353","article-title":"CD8+\u2009CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages","volume":"165","author":"Serbina","year":"2000","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.smim.2025.101959_bib106","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1073\/pnas.210391497","article-title":"Antimicrobial activity of MHC class I-restricted CD8+\u2009T cells in human tuberculosis","volume":"97","author":"Cho","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"_3","key":"10.1016\/j.smim.2025.101959_bib107","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/cid\/civ614","article-title":"B in TB: B cells as mediators of clinically relevant immune responses in tuberculosis","volume":"61","author":"Rao","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"163","key":"10.1016\/j.smim.2025.101959_bib108","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0218-2021","article-title":"The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group","volume":"31","author":"Melkie","year":"2022","journal-title":"Eur. Respir. Rev."},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005687","article-title":"Patients with tuberculosis have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment","volume":"12","author":"Joosten","year":"2016","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib110","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/IAI.00083-16","article-title":"Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques","volume":"84","author":"Phuah","year":"2016","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib111","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.4049\/jimmunol.178.11.7222","article-title":"B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis1","volume":"178","author":"Maglione","year":"2007","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.smim.2025.101959_bib112","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141895","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib113","doi-asserted-by":"crossref","first-page":"11447","DOI":"10.1038\/s41598-019-47836-8","article-title":"High glucose environments interfere with bone marrow-derived macrophage inflammatory mediator release, the TLR4 pathway and glucose metabolism","volume":"9","author":"Ayala","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib114","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1186\/s12879-019-4648-1","article-title":"Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy","volume":"19","author":"Kumar","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semnephrol.2007.01.006","article-title":"AGE, RAGE, and ROS in diabetic nephropathy","volume":"27","author":"Tan","year":"2007","journal-title":"Semin Nephrol."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib116","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/cclm-2013-0578","article-title":"Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?","volume":"52","author":"Marinakis","year":"2014","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.smim.2025.101959_bib117","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.actbio.2022.01.040","article-title":"Targeting extracellular matrix glycation to attenuate fibroblast activation","volume":"141","author":"Jang","year":"2022","journal-title":"Acta Biomater."},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib118","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.biomaterials.2008.11.038","article-title":"Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing","volume":"30","author":"Liao","year":"2009","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib119","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/wrr.12144","article-title":"Glycation of extracellular matrix proteins impairs migration of immune cells","volume":"22","author":"Haucke","year":"2014","journal-title":"Wound Repair Regen."},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/00365519009091067","article-title":"Impairment by glycation of immunoglobulin G Fc fragment function","volume":"50","author":"Dolhofer-Bliesener","year":"1990","journal-title":"Scand. J. Clin. Lab Invest"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J. Physiol. Pharm."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib122","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1006\/bbrc.2001.6312","article-title":"Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes","volume":"290","author":"Yamagishi","year":"2002","journal-title":"Biochem Biophys. Res Commun."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib123","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","article-title":"Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms","volume":"3","author":"Stirban","year":"2014","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib124","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1172\/JCI130546","article-title":"S100A8\/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis","volume":"130","author":"Scott","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib125","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1038\/s41598-019-45798-5","article-title":"Inhibition of the receptor for advanced glycation end-products in acute respiratory distress syndrome: a randomised laboratory trial in piglets","volume":"9","author":"Audard","year":"2019","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.smim.2025.101959_bib126","doi-asserted-by":"crossref","first-page":"12057","DOI":"10.1074\/jbc.M115.702399","article-title":"Regulation of receptor for advanced glycation end products (RAGE) ectodomain shedding and its role in cell function","volume":"291","author":"Braley","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib127","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/09031936.00029310","article-title":"Reduced soluble receptor for advanced glycation end-products in COPD","volume":"37","author":"Smith","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254198","article-title":"Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients","volume":"16","author":"Lazzari","year":"2021","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213991","article-title":"Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status","volume":"14","author":"da Silva","year":"2019","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.14283\/jpad.2018.18","article-title":"Development of Azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer's disease","volume":"5","author":"Burstein","year":"2018","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.smim.2025.101959_bib131","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/01.ATV.0000249630.02085.12","article-title":"Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes","volume":"26","author":"Cuccurullo","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.smim.2025.101959_bib132","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/aps.2013.8","article-title":"Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE\u2212\/\u2212 mice by downregulating the HMGB1-RAGE axis","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib133","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2014.03.025","article-title":"Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: randomized controlled trial (PioRAGE)","volume":"234","author":"Koyama","year":"2014","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib134","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1038\/s41467-023-41519-9","article-title":"Glycerol contributes to tuberculosis susceptibility in male mice with type 2 diabetes","volume":"14","author":"Martinez","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2025.101959_bib135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ebiom.2018.05.011","article-title":"Patients with concurrent tuberculosis and diabetes have a pro-atherogenic plasma lipid profile","volume":"32","author":"Vrieling","year":"2018","journal-title":"eBioMedicine"},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib136","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma","volume":"10","author":"Russell","year":"2009","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.smim.2025.101959_bib137","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1074\/jbc.M112.445056","article-title":"Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress","volume":"288","author":"Lee","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.smim.2025.101959_bib138","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1016\/j.vaccine.2012.06.084","article-title":"Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults","volume":"30","author":"Pathan","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib139","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.201802-0366OC","article-title":"Dose optimization of H56:IC31 vaccine for tuberculosis-endemic populations. A double-blind, placebo-controlled, dose-selection trial","volume":"199","author":"Suliman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/dom.14547","article-title":"Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study","volume":"24","author":"Marfella","year":"2022","journal-title":"Diabetes, Obes. Metab."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib141","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-020-0169-6","article-title":"BCG and BCG\u0394BCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines","volume":"5","author":"Segura-Cerda","year":"2020","journal-title":"NPJ Vaccin."},{"issue":"40","key":"10.1016\/j.smim.2025.101959_bib142","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1016\/j.vaccine.2016.08.035","article-title":"The BCG\u0394BCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo","volume":"34","author":"Pedroza-Rold\u00e1n","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib143","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1038\/s41467-020-19095-z","article-title":"Metformin enhances anti-mycobacterial responses by educating CD8+\u2009T-cell immunometabolic circuits","volume":"11","author":"B\u00f6hme","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2025.101959_bib144","unstructured":"World Health Organisation, Collaborative Framework for Care and Control of Tuberculosis and Diabetes. 2011, World Health Organization: Geneva."},{"key":"10.1016\/j.smim.2025.101959_bib145","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.19.0119","article-title":"Management of diabetes mellitus-tuberculosis: a guide to the essentialpractice","author":"Lin","year":"2019","journal-title":"Int. Union Tuberc. Lung Dis."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib146","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12879-017-2483-9","article-title":"Tuberculosis screening among persons with diabetes mellitus in Pune, India","volume":"17","author":"Mave","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib147","doi-asserted-by":"crossref","first-page":"12","DOI":"10.18773\/austprescr.2010.005","article-title":"Diagnostic tests: testing for tuberculosis","volume":"33","author":"Konstantinos","year":"2010","journal-title":"Aust. Prescr."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib148","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4046\/trd.2015.78.2.64","article-title":"Diagnosis of pulmonary tuberculosis: recent advances and diagnostic algorithms","volume":"78","author":"Ryu","year":"2015","journal-title":"Tube Respir. Dis. (Seoul. )"},{"key":"10.1016\/j.smim.2025.101959_bib149","doi-asserted-by":"crossref","first-page":"1025550","DOI":"10.3389\/fpubh.2022.1025550","article-title":"Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test","volume":"10","author":"He","year":"2022","journal-title":"Front Public Health"},{"issue":"10","key":"10.1016\/j.smim.2025.101959_bib150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029948","article-title":"Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan","volume":"9","author":"Lin","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib151","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062009","article-title":"Acceptability and feasibility of tuberculosis and diabetes mellitus bidirectional screening and joint treatment services in Malawi: a cross-sectional study and a policy document review","volume":"13","author":"Nyirenda","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib152","article-title":"Gaps in implementing bidirectional screening for tuberculosis and diabetes mellitus in myanmar: an operational research study","volume":"5","author":"Kyaw Soe","year":"2020","journal-title":"Trop. Med Infect. Dis."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib153","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12913-022-07612-3","article-title":"Challenges, opportunities, and potential roles of the private primary care providers in tuberculosis and diabetes mellitus collaborative care and control: a qualitative study","volume":"22","author":"Arini","year":"2022","journal-title":"BMC Health Serv. Res"},{"key":"10.1016\/j.smim.2025.101959_bib154","unstructured":"World Health Organization, Implementing the WHO Stop TB Strategy: A Handbook for National Tuberculosis Control Programmes. 2008, World Health Organization: Geneva."},{"key":"10.1016\/j.smim.2025.101959_bib155","unstructured":"Centers for Disease Control and Prevention. Treatment for TB Disease. 2023; Available from: \u3008https:\/\/www.cdc.gov\/tb\/topic\/treatment\/tbdisease.htm\u3009."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib156","article-title":"The interaction of diabetes and tuberculosis: translating research to policy and practice","volume":"6","author":"van Crevel","year":"2021","journal-title":"Trop. Med Infect. Dis."},{"key":"10.1016\/j.smim.2025.101959_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119701","article-title":"Multidrug-resistant tuberculosis","volume":"559","author":"Wulandari","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib158","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","article-title":"Update of drug-resistant tuberculosis treatment guidelines: a turning point","volume":"130","author":"Vanino","year":"2023","journal-title":"Int J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib159","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/S2213-2600(23)00426-5","article-title":"Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis","volume":"12","author":"Labuda","year":"2024","journal-title":"Lancet Respir. Med"},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib160","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S1473-3099(24)00223-8","article-title":"Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial","volume":"24","author":"Cevik","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.smim.2025.101959_bib161","article-title":"The use of BPaL containing regimen in the MDR\/PreXDR TB treatments in Thailand","volume":"34","author":"Sangsayunh","year":"2024","journal-title":"J. Clin. Tube Other Mycobact. Dis."},{"key":"10.1016\/j.smim.2025.101959_bib162","unstructured":"World Health Organisation. Guidelines on the management of latent tuberculosis infection. 2015, Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/136471\/9789241548908_eng.pdf?sequence=1."},{"key":"10.1016\/j.smim.2025.101959_bib163","unstructured":"WHO consolidated guidelines on tuberculosis Module 1: prevention - tuberculosis preventive treatment, second edition. 2024, World Health Organisation: Geneva."},{"key":"10.1016\/j.smim.2025.101959_bib164","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijid.2022.05.029","article-title":"Prevalence trends of latent tuberculosis infection at the global, regional, and country levels from 1990-2019","volume":"122","author":"Ding","year":"2022","journal-title":"Int J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib166","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s13063-022-06296-8","article-title":"Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial","volume":"23","author":"Ntinginya","year":"2022","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.smim.2025.101959_bib167","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.2022.24362","article-title":"Management of latent tuberculosis infection","volume":"329","author":"Kim","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib168","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bjid.2017.01.001","article-title":"Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility","volume":"21","author":"Marupuru","year":"2017","journal-title":"Braz. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib169","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1186\/s12879-019-4577-z","article-title":"Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study","volume":"19","author":"Lee","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib170","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/resp.13338","article-title":"Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes","volume":"23","author":"Lin","year":"2018","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib171","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s10096-018-3242-6","article-title":"Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up","volume":"37","author":"Ma","year":"2018","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib172","doi-asserted-by":"crossref","first-page":"299","DOI":"10.13005\/bpj\/1889","article-title":"Clinical evaluation of efficacy and safety of metformin addon therapy to standard ATT in newly diagnosed pulmonary tuberculosis patients","volume":"13","author":"Abinaya","year":"2020","journal-title":"Biomed. Pharmacol. J."},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib173","doi-asserted-by":"crossref","first-page":"16257","DOI":"10.1038\/s41598-020-73212-y","article-title":"Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis","volume":"10","author":"Frenkel","year":"2020","journal-title":"Sci. Rep."},{"issue":"263","key":"10.1016\/j.smim.2025.101959_bib174","doi-asserted-by":"crossref","first-page":"263ra159","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci. Transl. Med"},{"issue":"1","key":"10.1016\/j.smim.2025.101959_bib175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jiz064","article-title":"Metformin alters human host responses to Mycobacterium tuberculosis in healthy subjects","volume":"220","author":"Lachmandas","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib176","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/ciab964","article-title":"Randomized trial of metformin with anti-tuberculosis drugs for early sputum conversion in adults with pulmonary tuberculosis","volume":"75","author":"Padmapriydarsini","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.smim.2025.101959_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2024.102523","article-title":"Effect of Metformin on systemic chemokine responses during anti-tuberculosis chemotherapy","volume":"148","author":"Pavan Kumar","year":"2024","journal-title":"Tuberculosis"},{"issue":"9","key":"10.1016\/j.smim.2025.101959_bib178","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.smim.2025.101959_bib179","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/dom.12854","article-title":"Understanding and overcoming metformin gastrointestinal intolerance","volume":"19","author":"Bonnet","year":"2017","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.smim.2025.101959_bib180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: Current perspectives on causes and risk","volume":"65","author":"DeFronzo","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.smim.2025.101959_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"3","author":"Salpeter","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.smim.2025.101959_bib182","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.smim.2025.101959_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102801","article-title":"Effect of prediabetes on tuberculosis treatment outcomes: a study from South India","volume":"17","author":"Viswanathan","year":"2023","journal-title":"Diabetes Metab. Syndr."},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib184","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112108","article-title":"Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis","volume":"9","author":"Kumar","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.smim.2025.101959_bib185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41580-021-00392-4","article-title":"Machinery, regulation and pathophysiological implications of autophagosome maturation","volume":"22","author":"Zhao","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:47:00Z","timestamp":1762354020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532325000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":185,"alternative-id":["S1044532325000314"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2025.101959","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune dysregulation of diabetes in tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2025.101959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101959"}}